Coherus Oncology, Inc.CHRSNASDAQ
Loading
Net income as a percentage of revenue
5Y CAGR
+70.3%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
14.3x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 398.43% | +3631.1% |
| 2024 | 10.68% | +111.5% |
| 2023 | -92.48% | +33.1% |
| 2022 | -138.24% | -57.2% |
| 2021 | -87.92% | -416.3% |
| 2020 | 27.79% | +10.2% |
| 2019 | 25.23% | +100.2% |
| 2018 | -13453.66% | +12.1% |
| 2017 | -15306.56% | -22751.7% |
| 2016 | -66.98% | - |